COVID-19 Vaccine and Guillain-barre Syndrome COVID-19 Vaccine and Guillain-barre Syndrome
In this commentary, the authors warn against jumping to conclusions regarding an association of COVID-19 vaccines with Guillain-Barre syndrome, even if sporadic cases of GBS emerge.Brain (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - April 12, 2021 Category: Intensive Care Tags: Neurology & Neurosurgery Journal Article Source Type: news

No Proof COVID Vaccines Can Trigger Guillain-Barr é Syndrome
WEDNESDAY, April 7, 2021 -- Two people in the Johnson& Johnson COVID-19 vaccine trial developed Guillain-Barré syndrome, but it's highly doubtful the vaccine is to blame, according to a just-published case study. Although both people... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 7, 2021 Category: General Medicine Source Type: news

No Association Between COVID-19 and Guillain-Barré Syndrome
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - March 28, 2021 Category: Orthopaedics Tags: Snapshot Source Type: news

Janssen Announces U.S. FDA Approval of CABENUVA (rilpivirine and cabotegravir), the First Long-Acting Regimen for the Treatment of HIV
TITUSVILLE, N.J., January 21, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA (consisting of Janssen’s rilpivirine and ViiV Healthcare’s cabotegravir), the first and only once-monthly, long-acting regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults. The novel regimen was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen’s 25-year commitment to make HIV history. In the U.S., ViiV Healthcare is the marketing authorization holde...
Source: Johnson and Johnson - January 22, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

No Causal Link Found for COVID-19, Guillain-Barr é Syndrome
MONDAY, Jan. 4, 2021 -- There seems to be no causal association between COVID-19 and Guillain-Barr é syndrome (GBS), according to a study published online Dec. 14 in Brain. Noting that reports of GBS have emerged during the pandemic, Stephen Keddie,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 4, 2021 Category: Pharmaceuticals Source Type: news

CDC Issues COVID-19 Vaccine Guidance for Underlying Conditions CDC Issues COVID-19 Vaccine Guidance for Underlying Conditions
The guidance had specific information for people with HIV, weakened immune systems, and autoimmune conditions such as Guillain-Barre syndrome and Bell's palsy who are planning to get the vaccine.WebMD Health News (Source: Medscape Pulmonary Medicine Headlines)
Source: Medscape Pulmonary Medicine Headlines - December 28, 2020 Category: Respiratory Medicine Tags: Infectious Diseases News Source Type: news

No Link Seen Between COVID, Guillain-Barr é Syndrome
Guillain-Barré syndrome is a rare autoimmune condition that attacks the peripheral nervous system, typically causing numbness, weakness and pain. In severe cases, it can cause paralysis and is sometimes fatal. (Source: WebMD Health)
Source: WebMD Health - December 18, 2020 Category: Consumer Health News Source Type: news

No Link Seen Between COVID, Guillain-Barr é Syndrome
FRIDAY, Dec. 18, 2020 -- There's no evidence of a link between COVID-19 and a serious neurological condition called Guillain-Barr é syndrome, British researchers say. Guillain-Barré syndrome is a rare autoimmune condition that attacks the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 18, 2020 Category: General Medicine Source Type: news

No Link Seen Between COVID-19, Guillain-Barr é Syndrome
FRIDAY, Dec. 18, 2020 -- There's no evidence of a link between COVID-19 and a serious neurological condition called Guillain-Barré syndrome, British researchers say. Guillain-Barré syndrome is a rare autoimmune condition that attacks... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 18, 2020 Category: General Medicine Source Type: news

No association between COVID-19 and Guillain-Barr é syndrome
(University College London) Neuroscientists at UCL have found no significant association between COVID-19 and the potentially paralysing and sometimes fatal neurological condition Guillain-Barr é syndrome. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 13, 2020 Category: International Medicine & Public Health Source Type: news

Scientists Report First Case of Recurring Guillain-Barre Tied to COVID
THURSDAY, Dec. 10, 2020 -- The first known case of COVID-19 triggering a recurrence of Guillain-Barré syndrome has been reported by researchers. Guillain-Barré syndrome -- which can be sparked by viral and bacterial infections -- is a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 10, 2020 Category: General Medicine Source Type: news

Fears coronavirus can trigger Guillain-Barre syndrome in sufferers
In April 2020, a man complaining of weakness in his face and limbs tested positive for COVID-19 and triggered Guillain-Barré Syndrome, a rare disorder that can lead to paralyzation. (Source: the Mail online | Health)
Source: the Mail online | Health - December 9, 2020 Category: Consumer Health News Source Type: news

Rutgers reports first instance of COVID-19 triggering recurrent Guillain-Barr é Syndrome
(Rutgers University) Researchers at Rutgers Robert Wood Johnson Medical School have reported the first instance of COVID-19 triggering a recurrence of Guillain-Barr é Syndrome - a rare disorder where the body's immune system attacks nerves and can lead to respiratory failure and death. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - December 8, 2020 Category: Infectious Diseases Source Type: news

When Symptoms of Covid-19 Don ’t Go Away
Research is underway to assess the pandemic ’s long-term effects and find ways to prevent and treat lasting symptoms. (Source: NYT Health)
Source: NYT Health - October 12, 2020 Category: Consumer Health News Authors: Jane E. Brody Tags: Coronavirus (2019-nCoV) SARS (Severe Acute Respiratory Syndrome) Lungs Heart Post-Traumatic Stress Disorder Guillain-Barre Syndrome Source Type: news

SIMPONI ARIA ® (golimumab) Approved by the U.S. Food and Drug Administration for Active Polyarticular Juvenile Idiopathic Arthritis and Extension of Its Active Psoriatic Arthritis Indication in Patients 2 Years of Age and Older
HORSHAM, PA, September 30, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved SIMPONI ARIA® (golimumab) for patients 2 years of age and older for the treatment of active pJIA and has extended the PsA indication for this same patient population. “This latest FDA approval of SIMPONI ARIA for pediatric use in active pJIA and active PsA not only brings a new option to young patients living with these diseases but also adds to the growing body of evidence for this treatment,” said Mathai Mammen, M.D., Ph.D., Glo...
Source: Johnson and Johnson - September 30, 2020 Category: Pharmaceuticals Source Type: news

Coronavirus-infected man, 57, is left paralysed after the disease triggers a rare condition
The Briton was rushed to A&E on April 13 after struggling to stand upright or move his arms, where a swab confirmed he was infected with Covid-19. He was diagnosed with Guillain-Barré syndrome. (Source: the Mail online | Health)
Source: the Mail online | Health - July 17, 2020 Category: Consumer Health News Source Type: news

Stanford biotech spinout snares $100M round on path toward IPO
Annexon Inc., a Stanford University spinout targeting a protein that could play a role in neurodegeneration and autoimmune and eye diseases, closed a $100 million round that may signal interest in an IPO. The South San Francisco company, led by President and CEO Ted Love, is looking to inhibit a pathway called complement. It has pushed two drugs into clinical trials and has raised more than $250 million. One drug, called ANX-005, is a monoclonal antibody in a Phase I/II study against Guillain-Barr é… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 2, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

COVID-19 Update: Guillain-Barr é , States Quarantining Visitors COVID-19 Update: Guillain-Barr é , States Quarantining Visitors
These are the coronavirus stories you need to know about today.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - June 24, 2020 Category: Emergency Medicine Tags: Infectious Diseases News Source Type: news

First Reported US Case of Guillain-Barr é Linked to COVID-19 First Reported US Case of Guillain-Barr é Linked to COVID-19
A 54-year-old man from Pittsburgh is believed to represent the first documented US case of Guillain-Barre syndrome occurring soon after SARS-CoV-2 infection.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - June 24, 2020 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Coronavirus Vaccine: Here Are The Latest Developments
(CNN) — While coronavirus keeps spreading and killing with impunity, the world waits for a vaccine that could quash the pandemic. But details and timelines keep shifting. Here’s the latest on where we stand in the race for a vaccine: When will a Covid-19 vaccine be available to the public? No one’s sure yet, but the target is sometime in early 2021. Vaccines in development around the world are in various stages of testing. Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said he’s confident one of the vaccine candidates will be proven safe and effective by th...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - June 8, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Closures Covid-19 Boston, MA Health Healthcare Status Coronavirus Coronavirus Vaccine Moderna Therapeutics Source Type: news

Janssen Announces Submission of Two Applications to U.S. FDA Seeking Approval of SIMPONI ARIA ® (golimumab) for the Treatment of Polyarticular Juvenile Idiopathic Arthritis and Juvenile Psoriatic Arthritis
HORSHAM, PA, April 24, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the submission of two supplemental Biologics License Applications (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of SIMPONI ARIA® (golimumab) for the treatment of polyarticular juvenile idiopathic arthritis (pJIA) and juvenile psoriatic arthritis (jPsA), in patients two years of age and older in combination with methotrexate. If approved for these indications, SIMPONI ARIA would be the first anti-tumor necrosis factor (TNF)-alpha biologic agent administered by intravenous infusion av...
Source: Johnson and Johnson - April 24, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Some COVID Patients Develop Guillain-Barre
The symptoms of the disorder "include weakness, areflexia [absence of reflexes], paresthesia [tingling], and in some cases facial weakness and ataxia [poor balance]," Geraci said. (Source: WebMD Health)
Source: WebMD Health - April 21, 2020 Category: Consumer Health News Source Type: news

More Evidence Supports COVID-19/Guillain-Barr é Link
Clinicians in Italy report five more cases of Guillain-Barre syndrome that emerged 5 to 10 days after COVID-19 diagnosis. (Source: WebMD Health)
Source: WebMD Health - April 21, 2020 Category: Consumer Health News Source Type: news

Some COVID-19 Patients Stricken by Guillain-Barre Syndrome
TUESDAY, April 21, 2020 -- Studies are beginning to show that, in rare cases, people with severe COVID-19 may develop the serious nervous system disorder known as Guillain-Barre syndrome. " Guillain-Barre syndrome is a well-known condition in which... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 21, 2020 Category: General Medicine Source Type: news

More Evidence Supports COVID-19/Guillain-Barr é Link More Evidence Supports COVID-19/Guillain-Barr é Link
Clinicians in Italy report five more cases of Guillain-Barre syndrome that emerged 5 to 10 days after COVID-19 diagnosis.Medscape Medical News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - April 20, 2020 Category: Infectious Diseases Tags: Neurology & Neurosurgery News Source Type: news

United Kingdom Site Content,clinician health and well-being, work-life balance, balancing career and personal life, balancing personal and professional life,guillain barre syndrome,hepatitis, viral hepatitis,drug/treatment safety,lung,geriatrics (elder care),infection control,infection in the immunocompromised host,pandemic,Coronavirus, 2019 Novel Coronavirus, 2019-nCoV, Wuhan coronavirus, Human c
These are the coronavirus stories you need to know about today. (Source: WebMD Health)
Source: WebMD Health - April 10, 2020 Category: Consumer Health News Source Type: news

First Case of COVID-19 Presenting as Guillain-Barre ´ Reported
An older woman returning from Wuhan during the pandemic presented with signs and symptoms that suggested Guillain-Barre´ syndrome. She was subsequently found to have COVID-19. (Source: WebMD Health)
Source: WebMD Health - April 10, 2020 Category: Consumer Health News Source Type: news

First Case of COVID-19 Presenting as Guillain-Barre ́ Reported First Case of COVID-19 Presenting as Guillain-Barre ́ Reported
An older woman returning from Wuhan during the pandemic presented with signs and symptoms that suggested Guillain-Barre ́ syndrome. She was subsequently found to have COVID-19.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - April 9, 2020 Category: Emergency Medicine Tags: Neurology & Neurosurgery News Source Type: news

Neurologic Symptoms and COVID-19: What's Known, What Isn't
Some patients with COVID-19 are also presenting with neurologic disorders, including encephalopathy, stroke, Guillain-Barre syndrome and more. What it means, however, is at this point unclear. (Source: WebMD Health)
Source: WebMD Health - April 7, 2020 Category: Consumer Health News Source Type: news

Neurologic Symptoms and COVID-19: What's Known, What Isn't Neurologic Symptoms and COVID-19: What's Known, What Isn't
Some patients with COVID-19 are also presenting with neurologic disorders, including encephalopathy, stroke, Guillain-Barre syndrome and more. What it means, however, is at this point unclear.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - April 5, 2020 Category: Emergency Medicine Tags: Neurology & Neurosurgery News Source Type: news

Nitrous oxide recreational abuse presenting with myeloneuropathy and mimicking Guillain-Barre syndrome - Algahtani H, Shirah B, Abdelghaffar N, Abuhawi O, Alqahtani A.
The recreational use of nitrous oxide (N2O) is increasing in festivals, university parties, clubs, private residences, and parks. The abuse of N2O has serious complications of the central and peripheral nervous system. In this article... (Source: SafetyLit)
Source: SafetyLit - March 26, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Bachelorette star's rare immune disease left him too weak to carry his kids
The Bachelorette stars JP Rosenbaum and Ashley Hebert Rosenbaum, say he had mostly recovered after being stricken down last month with the rare autoimmune disorder Guillain-Barré syndrome. (Source: the Mail online | Health)
Source: the Mail online | Health - January 14, 2020 Category: Consumer Health News Source Type: news

Antibodies gather and form a circle for defensive attack
(National Institutes of Natural Sciences) Antibodies play a crucial role in our immune system by linking antigen recognition with complement activation for attacking foreign cells. Using high-speed atomic force microscopy, collaborative groups, including researchers at National Institutes of Natural Sciences and Nagoya City University, have successfully visualized the dynamic process of antigen-mediated interplay between antibodies and a complement component on membranes. Their findings provide mechanistic insights into the molecular processes behind Guillain-Barr é syndrome. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 6, 2020 Category: International Medicine & Public Health Source Type: news

Bachelorette's JP Rosenbaum back home after revealing that he was left paralyzed from rare disorder
JP Rosenbaum is back home and on treatment after revealing he's been diagnosed with Guillain-Barré syndrome, a rare disorder that causes partial or, in some cases, complete paralysis. (Source: the Mail online | Health)
Source: the Mail online | Health - December 11, 2019 Category: Consumer Health News Source Type: news

The Toll Mounts From a Mystery Disease Some Call “The New Polio”
Carter Roberts’ motorized wheelchair didn’t arrive until the day he died. It had been a long time coming and his parents had fought hard to get it. The chair cost more than $32,000 and the insurance companies wouldn’t cover it, so the family went to court. One insurer eventually agreed to pay for some components of the chair but not the whole thing. And then none of it mattered anyway. On Sept. 22, 2018, the Roberts’ doorbell rang and the chair was delivered. Also on Sept. 22, 2018, Carter died, just three months shy of his sixth birthday. He had been largely paralyzed for the final two years of his...
Source: TIME: Health - October 9, 2019 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized Infectious Disease viruses Source Type: news

Reversible Stress Cardiomyopathy in Guillain-barre Syndrome Reversible Stress Cardiomyopathy in Guillain-barre Syndrome
This case documents stress cardiomyopathy as a potentially lethal complication of Guillain-Barre syndrome, highlighting the need for early diagnosis.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 10, 2019 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Woman left paralyzed from the waist down after contracting a rare autoimmune disorder from the FLU
Morgan Williams, 23, was living in Kona, Hawaii, when she fell ill with the flu in March 2018 before she was paralyzed from the waist down. She was soon diagnosed with Guillain-Barré syndrome. (Source: the Mail online | Health)
Source: the Mail online | Health - July 9, 2019 Category: Consumer Health News Source Type: news

Guillain-Barr é Syndrome and Vaccines: Time to Say Yes? Guillain-Barr é Syndrome and Vaccines: Time to Say Yes?
A woman with a history of Guillain-Barre syndrome presents for care. What vaccines would you give her?Medscape Internal Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 2, 2019 Category: Consumer Health News Tags: Internal Medicine Clinical Case Source Type: news

That & #039;s a First: FDA Tackles STDs, Zika, and Prosthetic Joint Infection
The U.S. diagnostic market celebrated three regulatory firsts last week.  1. FDA Authorizes Marketing of First Zika Test Until now, tests for detecting Zika virus immunoglobulin (IgM) antibodies in blood were only authorized for emergency use under FDA's Emergency Use Authorization (EUA) authority. On Thursday, the agency said it has authorized marketing of the ZIKV Detect 2.0 IgM Capture ELISA under the agency's traditional premarket authority. The test is manufactured by InBios International. “At the onset of the Zika virus outbreak, when little was known about the disease or how...
Source: MDDI - May 24, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance IVD Source Type: news

Boy, 5, left paralyzed from the waist down after contracting a rare autoimmune disorder from the flu
Brysen Mills, five, from Paris, Illinois, was diagnosed with Guillain-Barré syndrome, a rare disorder in which the body's immune system attacks its peripheral nervous system (Source: the Mail online | Health)
Source: the Mail online | Health - February 26, 2019 Category: Consumer Health News Source Type: news

Texas father-of-two who was struck down with sudden paralysis completes Half Ironman triathalon
Trent Fielder, 44, from Burleson, Texas, was paralyzed in 2011 and diagnosed with Guillain-Barré syndrome, a rare autoimmune disorder in which the body's immune system attacks the nerves. (Source: the Mail online | Health)
Source: the Mail online | Health - February 20, 2019 Category: Consumer Health News Source Type: news

Has the mystery of Alexander the Great's death been solved?
Florida researchers concluded  he met his demise thanks to the neurological disorder Guillain-Barré Syndrome (GBS), which can leave sufferers paralyzed. (Source: the Mail online | Health)
Source: the Mail online | Health - January 29, 2019 Category: Consumer Health News Source Type: news

Blogger paralysed after stroking a STRAY CAT on holiday  
Gemma Birch, 24, of Southport, formed a bond with a stray cat she named Catarina on holiday to Portugal. She caught food poisoning from the cat, which triggered Guillain-Barr é syndrome. (Source: the Mail online | Health)
Source: the Mail online | Health - January 23, 2019 Category: Consumer Health News Source Type: news

What is the Recurrence Rate for Guillian-Barr é Syndrome and Should She Get An Influenza Vaccine?
Discussion Guillian-Barré syndrome (GBS) is an acquired, acute, inflammatory, demyelinating polyneuropathy. It is the most common cause of acute and subacute flaccid paralysis in children. GBS causes about 0.4-1.3 cases per 100,000 persons/year in children. It can occur in any age group and the incidence increases among all age groups until a peak in the 50s. Both genders are affected and there may be a slight increase in males. GBS usually occurs 2-4 weeks after a prodromal gastroenteritis or respiratory illness. GBS causes autoantibody production against Schwann cells of the neuron and the axon itself. There is ...
Source: PediatricEducation.org - November 19, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Regional Variation of Guillain-Barre Syndrome Regional Variation of Guillain-Barre Syndrome
A new study demonstrates that geographical factors have a major influence on clinical variants, disease severity, electrophysiological subtype, and outcome of Guillain-Barre syndrome.Brain (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 31, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Yes, You Should Get a Flu Shot in 2018. Here ’s Everything to Know
The 2017-2018 flu season was a bad one. The dominant viral strain, H3N2, was a particularly severe form of influenza, leading to widespread and serious illness across the country. The flu and its complications killed around 80,000 people last year, the CDC estimates, including 180 children. That’s the highest flu death toll in four decades. Experts say early indications suggest that this year’s flu season will be milder, but the memory of last winter should still serve as motivation to get the flu shot this fall. Here’s what you need to know about the 2018 flu shot. When should I get the flu shot? The CD...
Source: TIME: Health - October 5, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime public health Source Type: news

Father-of-three left paralyzed by rare nerve condition day after returning from vacation in Bali
Craig Hardy, 52, from Perth, Australia, has been hospitalized with Guillain-Barr é syndrome, a rare disorder in which the immune system attacks your peripheral nervous system. (Source: the Mail online | Health)
Source: the Mail online | Health - September 6, 2018 Category: Consumer Health News Source Type: news

NFL player ’s diagnosis shines light on Guillain-Barré syndrome
Dallas Cowboys center Travis Frederick announced that he has been diagnosed with the rare neurological disorder (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 23, 2018 Category: Consumer Health News Source Type: news

Do-it-all veteran, mother-of-three and singer who was suddenly paralyzed by mysterious rare disease
Deanna Wheeler, 31, found herself almost instantaneously paralyzed last month, first from the waist down, then completely, by the rare autoimmune disorder, Guillain-Barre Syndrome. (Source: the Mail online | Health)
Source: the Mail online | Health - June 1, 2018 Category: Consumer Health News Source Type: news